Logo


Sanofi-Aventis to take longer on Shan5 relaunch

French vaccine major Sanofi-Aventis is expected to relaunch the pentavalent Shan5 vaccine produced by its Indian subsidiary, Shantha Biotech, only in 2013. It does not want to take further chances after the World Health Organisation (WHO) removed the vaccine from its prequalification list in July last year. “We first thought it would be ready for undergoing the inspection process in January next year. However, the company is conducting more stability studies on the vaccine. Therefore, it may take a longer time before it goes through the usual approval process,” a senior official ...